Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
7-(Diethylamino)coumarin-3-carboxylic acid (AC194)
Cat.#: ASSD-194
Specifications
Description 7-(Diethylamino)coumarin-3-carboxylic acid, a blue fluorescent label, is used for labeling amine modification and protein conjugation. Synonyms DEAC Size 100 mg Applications An amine-reactive fluorescent label Molecule Weight 261.27 Molecular formula C14H15NO4 CAS Number 50995-74-9 Purity >98% Solubility Soluble in DMF and DMSO Storage Store at 4° C Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ASSD-192 4-Fluoro-7-nitrobenzofurazan (AC192) 5 mg, 25 mg, 50 mg inquiry ASSD-178 5-(Iodoacetamido)fluorescein (AC178) 25 mg, 100 mg, 250 mg inquiry ASSD-181 Nitrofluorescein, Isomer 1 (AC181) 1 g inquiry ASSD-223 Antifade Fluorescence Mounting Medium (aqueous) (AC223) 10 mL inquiry ASSD-105 Hoechst 33342 (AC105) 10 mg, 100 mg inquiry ASSD-139 Adenosine A1AR Affinity-Based Probe (AfBP) (AC139) 50 μg inquiry ASSD-203 Bis(2,2′-bipyridine)-4,4′-dicarboxybipyridine-ruthenium di(N-succinimidyl ester) bis(hexafluorophosphate) (AC203) 5 mg inquiry ASSD-218 6-Carboxy-2′,7′-dichlorofluorescein-3′,6′-diacetatesuccinimidyl Ester (AC218) 25 mg inquiry ASSD-200 Ethylenediamine N-[(Cyanine 3) Monofunctional Hexanoic Acid]-N′-[3-difluoromethyl-4-phosphoanilinamidosuccinic Acid] Diamide (AC200) 500 μg inquiry ASSD-157 Eosin B (AC157) 1g, 5g inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket